nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
|
Oellerich, Michael |
|
|
19 |
11 |
p. 3087-3099 |
artikel |
2 |
A caveat to the MISSION Act: Perspective from a Veterans Administration transplant center
|
Lockridge, Joseph |
|
|
19 |
11 |
p. 3210-3211 |
artikel |
3 |
Accelerating kidney allocation: Simultaneously expiring offers
|
Mankowski, Michal A. |
|
|
19 |
11 |
p. 3071-3078 |
artikel |
4 |
Acute complications in both recipients of a kidney allograft pair from the same donor
|
Lurje, Isabella |
|
|
19 |
11 |
p. 3207-3209 |
artikel |
5 |
American Journal of Transplantation: Volume 19, Number 11, November 2019
|
|
|
|
19 |
11 |
p. i |
artikel |
6 |
A nonlinear relationship between visceral adipose tissue and frailty in adult lung transplant candidates
|
Anderson, Michaela R. |
|
|
19 |
11 |
p. 3155-3161 |
artikel |
7 |
Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation
|
Brosseau, Carole |
|
|
19 |
11 |
p. 3162-3175 |
artikel |
8 |
CCL2/MCP-1 and CXCL12/SDF-1 blockade by L-aptamers improve pancreatic islet engraftment and survival in mouse
|
Citro, Antonio |
|
|
19 |
11 |
p. 3131-3138 |
artikel |
9 |
CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients
|
Glass, Carolyn |
|
|
19 |
11 |
p. 3149-3154 |
artikel |
10 |
Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study
|
Barten, Markus J. |
|
|
19 |
11 |
p. 3006-3017 |
artikel |
11 |
DeTOXifying exhausted T cells
|
Alegre, Maria-Luisa |
|
|
19 |
11 |
p. 2965 |
artikel |
12 |
Drug Policy in the Real World
|
Pullen, Lara C. |
|
|
19 |
11 |
p. 2963-2964 |
artikel |
13 |
Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death
|
Valentino, Pamela L. |
|
|
19 |
11 |
p. 3114-3123 |
artikel |
14 |
Get on with it!—A novel allocation strategy to reduce kidney discards
|
Locke, Jayme E. |
|
|
19 |
11 |
p. 2971-2972 |
artikel |
15 |
Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices
|
Meites, Elissa |
|
|
19 |
11 |
p. 3202-3206 |
artikel |
16 |
Hypoxia protects the liver from Small For Size Syndrome: A lesson learned from the associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure in rats
|
Dili, Alexandra |
|
|
19 |
11 |
p. 2979-2990 |
artikel |
17 |
Importance of incorporating standardized, verifiable, objective metrics of organ procurement organization performance into discussions about organ allocation
|
Goldberg, David |
|
|
19 |
11 |
p. 2973-2978 |
artikel |
18 |
Isolated pancreas transplantation: Is rank list position related to outcomes of imported grafts?
|
Adler, Joel T. |
|
|
19 |
11 |
p. 3124-3130 |
artikel |
19 |
Lessons from the real world: HCV-infected donor kidney transplantation as standard practice
|
Durand, Christine M. |
|
|
19 |
11 |
p. 2969-2970 |
artikel |
20 |
mTOR inhibitors vs calcineurin inhibitors: A Catch-22—preventing nephrotoxicity or acute allograft rejection after heart transplantation
|
Tsay, Annie J. |
|
|
19 |
11 |
p. 2967-2968 |
artikel |
21 |
Noncirrhotic hyperammonemia after deceased donor kidney transplantation: A case report
|
Li, George Z. |
|
|
19 |
11 |
p. 3197-3201 |
artikel |
22 |
Nonvascularized human skin chronic allograft rejection
|
Rotman, Samuel |
|
|
19 |
11 |
p. 3191-3196 |
artikel |
23 |
Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature
|
Qualls, David A. |
|
|
19 |
11 |
p. 3185-3190 |
artikel |
24 |
Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System
|
Jackson, Kyle R. |
|
|
19 |
11 |
p. 3079-3086 |
artikel |
25 |
Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts
|
Linares-Cervantes, Ivan |
|
|
19 |
11 |
p. 2991-3005 |
artikel |
26 |
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
|
Iavarone, Massimo |
|
|
19 |
11 |
p. 3176-3184 |
artikel |
27 |
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
|
Redfield, Robert R. |
|
|
19 |
11 |
p. 3035-3045 |
artikel |
28 |
Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals
|
La Hoz, Ricardo M. |
|
|
19 |
11 |
p. 3058-3070 |
artikel |
29 |
Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation
|
Senev, Aleksandar |
|
|
19 |
11 |
p. 3100-3113 |
artikel |
30 |
Supplementing preservation solution with mitochondria-targeted H2S donor AP39 protects cardiac grafts from prolonged cold ischemia–reperfusion injury in heart transplantation
|
Zhu, Cuilin |
|
|
19 |
11 |
p. 3139-3148 |
artikel |
31 |
Three-year follow-up of aviremic hepatitis C–positive kidneys
|
Kling, Catherine E. |
|
|
19 |
11 |
p. 3212-3213 |
artikel |
32 |
Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
|
Molnar, Miklos Z. |
|
|
19 |
11 |
p. 3046-3057 |
artikel |
33 |
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study
|
Berger, Stefan P. |
|
|
19 |
11 |
p. 3018-3034 |
artikel |